Tag: ACT

5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials

5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials

HIT Consultant

Melissa Mooney, Director of eCOA Solutions Engineering at IQVIAIn the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the side effects are tolerable for patients and how these treatments could be improved from the patient’s…

Continue Reading
Monday Morning Update 2/20/23

Monday Morning Update 2/20/23

HIStalk

Top News

The VA postpones its planned July 2023 Oracle Cerner go-live at its Ann Arbor, MI facilities until later this year or early in 2024.
The service region is concerned about “how well EHRM would interact with VA Ann Arbor’s vital medical research mission.”

Reader Comments From AT: “Re: pet peeves with service industry words and phrases. ‘I appreciate you,’ following my thanking you and leaving you a tip, which suggests that we are like-minded, decent people even though you have no way of knowing that. Second is thanking someone with ‘of course,” implying that I’m either too stupid to know…

Continue Reading
Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

MedCity News

Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.
Before Covid-19 diverted attention away from this problem, President Trump signed on to the SUPPORT for Patients and Communities Act of 2018, instating sweeping legislation for initiatives to address the opioid epidemic. The bill, among other initiatives, requires electronic prescriptions for controlled substances (EPCS) for any covered part D drug. Although the official start of the mandate was delayed two years to January 1, 2023, the importance of this federal intervention cannot be…

Continue Reading
Decline of Telehealth During the Pandemic and After

Decline of Telehealth During the Pandemic and After

MedCity News

The pandemic has forced healthcare organizations to rely heavily on telehealth services. In 2020, virtual visits accounted for more than a quarter of all outpatient visits in the U.S., and they’ve been steadily increasing since then. But there is a flip side to this trend. Recent data shows that telehealth is declining in healthcare, which could create a burden for both healthcare systems and patients. Let’s take a look at why this is happening and what can be done about it.
Reasons behind the decline  There are several factors driving the decline in telehealth utilization in healthcare settings. One reason is cost…

Continue Reading
Chiesi Wins FDA Approval for First Drug to Treat Ultra-Rare Enzyme Deficiency

Chiesi Wins FDA Approval for First Drug to Treat Ultra-Rare Enzyme Deficiency

MedCity News

A Chiesi Farmaceutici drug for a rare enzyme deficiency is now approved by the FDA, making it the first U.S. treatment for a disorder that leads to a range of cognitive and muscle problems.
The regulatory decision announced late Thursday covers the treatment of children and adults who have alpha-mannosidosis (AM), a disease caused by a genetic mutation that leads to defective or inactive forms of an enzyme called alpha-D-mannosidase. Chiesi’s drug, velmanase alfa, is an engineered version of that enzyme. The privately held Italian company will market its new FDA-approved drug as Lamzede, the same name for the product in Europe,…

Continue Reading
Health benefits platform Collective Health announces layoffs

Health benefits platform Collective Health announces layoffs

MobiHealthNews

Collective Health, a health benefits management platform, has laid off 54 employees as it arranges its workforce to better align with customer needs. The company’s CEO, Ali Diab, announced the layoffs on LinkedIn, saying the employees were being let go due to a “workforce reduction,” while urging companies that may encounter those employees during the hiring process to provide them with “strong consideration.”
Collective Health acts as a third-party health benefits administrator, bringing companies’ various benefits into one platform to let employers manage their offerings while assisting employees with navigating their healthcare.
“We can confirm that as part of a restructuring of our workforce,…

Continue Reading
What the metaverse and virtual reality can contribute to healthcare

What the metaverse and virtual reality can contribute to healthcare

Healthcare IT news

The so-called metaverse and virtual reality are up-and-coming technologies that could offer healthcare quite a bit.Medical practitioners can test out the effectiveness of new surgical methods in the metaverse before attempting on real patients. And as an extension of telehealth, medical professionals can use virtual reality to access patients and examine them virtually.
What exactly is the metaverse? How does virtual reality work? What can they contribute to healthcare? And where will these technologies offer innovations in the years to come?
To get answers to these questions, we sat down with Pari Natarajan, CEO of Zinnov, a global management and consulting firm focusing…

Continue Reading
DrFirst Acquires Diagnotes Secure Messaging and Care Coordination Platform

DrFirst Acquires Diagnotes Secure Messaging and Care Coordination Platform

Healthcare IT Today

Expands Backline by DrFirst’s Capabilities for Clinical Communications in Health Systems and Beyond
Healthcare technology pioneer DrFirst today announced it has acquired select assets of Indianapolis-based Diagnotes. The acquisition will allow Backline by DrFirst to expand its capabilities to break through communication silos in healthcare at each stage of the patient care journey, promote positive patient outcomes, and enhance satisfaction for staff and patients.
Diagnotes provides a suite of team-based, patient-centered collaboration tools built specifically for the healthcare sector. The app increases clinicians’ productivity and the quality of patient care by allowing healthcare providers to communicate with colleagues in their system and affiliates in other systems. The…

Continue Reading
The Adderall Shortage

The Adderall Shortage

MedCity News

The current Adderall shortage is of serious concern to both patients who have attention deficit hyperactivity disorder (ADHD) and clinicians. This shortage cannot be quickly alleviated by a simple increase in the amount of medication manufactured, unless the upper limit to the amount of Adderall’s active ingredient that can be manufactured in a given year is raised by the Drug Enforcement Agency (DEA). The limit has been imposed because the active ingredient can be abused as a recreational drug. It is necessary to control the supply of any medication with abuse liability, but this must be achieved without compromising the legitimate…

Continue Reading